Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Different Dose Escalation Regimens for NNC0662-0419 in Participants With Obesity

NCT07639021 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT07639021
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07639021 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Different Dose Escalation Regimens for NNC0662-0419 in Participants With Obesity
Lead sponsor
Novo Nordisk A/S
Phase
Phase 2
Overall status
Active, not recruiting
Start date
June 9, 2026
Completion date
June 14, 2027
Enrollment
233 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

obesity